Isi Artikel Utama

Aprilia Husain
Miski Aghnia Khairinisa
Widya Norma Insani

Page: 1765-1774

Abstrak

Unintended medication discrepancies (UMD) sering terjadi selama transisi perawatan, terutama di negara berpenghasilan rendah dan menengah (LMICs), yang masih memiliki berbagai keterbatasan sistem seperti ketiadaan protokol standar, sistem informasi yang tidak terintegrasi, dan minimnya farmasis klinik terlatih. Tinjauan naratif ini bertujuan untuk mengeksplorasi prevalensi, karakteristik, dan faktor-faktor penyebab UMD di LMICs berdasarkan analisis terhadap 10 studi terpilih. Jenis discrepancy yang paling sering dilaporkan adalah penghilangan obat (omission), terutama pada pasien lanjut usia dengan terapi kompleks. Faktor-faktor yang mempengaruhi kejadian UMD meliputi polifarmasi, dokumentasi yang tidak memadai, ketiadaan protokol rekonsiliasi, keterlibatan farmasis yang rendah, dan komunikasi lintas fasilitas yang buruk. Meskipun terdapat berbagai keterbatasan sistem, intervensi yang dipimpin oleh farmasis terbukti mampu menurunkan angka UMD secara signifikan bahkan di lingkungan terbatas. Perbandingan dengan negara maju menunjukkan bahwa penggunaan sistem digital, kebijakan yang terstandar, dan integrasi peran farmasis sangat membantu dalam meningkatkan keselamatan pengobatan saat transisi perawatan. Kajian ini menyimpulkan bahwa penanggulangan UMD di LMICs memerlukan pendekatan multidimensi seperti pengembangan kebijakan nasional, pelibatan farmasis dalam tim klinik, implementasi teknologi yang sesuai konteks, dan penguatan pendidikan farmasi untuk meningkatkan keselamatan pasien.

Unduhan

Data unduhan belum tersedia.

Rincian Artikel

Cara Mengutip
Husain, A., Khairinisa , M. A., & Insani , W. N. (2025). Unintended Medication Discrepancies (UMD) Pada Saat Rekonsiliasi Transfer dalam Konteks Negara Berpenghasilan Rendah dan Menengah : Tinjauan Naratif. Journal of Pharmaceutical and Sciences, 8(3), 1765–1774. https://doi.org/10.36490/journal-jps.com.v8i3.983
Bagian
Review Article

Referensi

Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital Background: Studies of hospitalized patients identify safety as a. Ann Intern Med 2003;138:161–7. DOI: https://doi.org/10.7326/0003-4819-138-3-200302040-00007

El Morabet N, Uitvlugt EB, van den Bemt BJF, van den Bemt PMLA, Janssen MJA, Karapinar-Çarkit F. Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review. J Am Geriatr Soc 2018;66:602–8. https://doi.org/10.1111/jgs.15244. DOI: https://doi.org/10.1111/jgs.15244

Hannum SM, Abebe E, Xiao Y, Brown R, Peña IM, Gurses AP. Engineering care transitions: Clinician perceptions of barriers to safe medication management during transitions of patient care. Appl Ergon 2021;91. https://doi.org/10.1016/j.apergo.2020.103299. DOI: https://doi.org/10.1016/j.apergo.2020.103299

Dong PTX, Pham VTT, Nguyen TT, Nguyen HTL, Hua S, Li SC. Unintentional Medication Discrepancies at Admission Among Elderly Inpatients with Chronic Medical Conditions in Vietnam: A Single-Centre Observational Study. Drugs - Real World Outcomes 2022;9:141–51. https://doi.org/10.1007/s40801-021-00274-3. DOI: https://doi.org/10.1007/s40801-021-00274-3

Mekonnen AB, McLachlan AJ, Brien JAE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: A systematic review and meta-analysis. BMJ Open 2016;6. https://doi.org/10.1136/bmjopen-2015-010003. DOI: https://doi.org/10.1136/bmjopen-2015-010003

Ganachari M, Parghi B. Discrepancies occurred during multiple care transition points in a tertiary care hospital in India. Asian J Pharm Clin Res 2022. https://doi.org/10.22159/ajpcr.2022.v15i6.44569.

Ayalew M, Seifu MF. Prevalence of medication discrepancies and associated factors at hospital admission in Ethiopia. Integr Pharm Res Pract 2020. https://doi.org/10.2147/IPRP.S251770.

Alghamdi DS, Alhrasen M, Kassem A, Alwagdani A, Tourkmani AM, Alnowaiser N, et al. Implementation of medication reconciliation at admission and discharge in Ministry of Defense Health Services hospitals: A multicentre study. BMJ Open Qual 2023;12:1–9. https://doi.org/10.1136/bmjoq-2022-002121. DOI: https://doi.org/10.1136/bmjoq-2022-002121

Aires-Moreno M, Alcântara Jr A, Silva E. Medication discrepancies in transition of care of pediatric patients in a Brazilian university hospital. Pharm Pract (Granada) 2021. https://doi.org/10.18549/PharmPract.2021.4.2159.

Nguyen T, Pham H. Medication discrepancies and their potential harms in Vietnamese geriatric patients. Geriatr Gerontol Int 2023. https://doi.org/10.1111/ggi.14622. DOI: https://doi.org/10.1111/ggi.14622

Tamiru A, Edessa D, Sisay M, Mengistu G. Magnitude and factors associated with medication discrepancies identified through medication reconciliation at care transitions of a tertiary hospital in eastern Ethiopia. BMC Res Notes 2018;11:1–7. https://doi.org/10.1186/s13104-018-3668-z. DOI: https://doi.org/10.1186/s13104-018-3668-z

Ofori-Asenso R, Agyeman AA. Patient safety in Sub-Saharan Africa: a narrative review. Int J Qual Heal Care 2019. https://doi.org/10.1093/intqhc/mzz091. DOI: https://doi.org/10.1093/intqhc/mzz091

Chiewchantanakit D, Meakchai A, Pituchaturont N, Dilokthornsakul P, Dhippayom T. The effectiveness of medication reconciliation to prevent medication error: A systematic review and meta-analysis. Res Soc Adm Pharm 2020;16:886–94. https://doi.org/10.1016/j.sapharm.2019.10.004. DOI: https://doi.org/10.1016/j.sapharm.2019.10.004

Gala P, Moshokgo V, Seth B, Ramasuana K, Kazadi E, M’buse R, et al. Medication Errors and Blood Pressure Control Among Patients Managed for Hypertension in Public Ambulatory Care Clinics in Botswana. J Am Heart Assoc 2020;9:1–10. https://doi.org/10.1161/JAHA.119.013766. DOI: https://doi.org/10.1161/JAHA.119.013766

Altawalbeh SM, Sallam NM, Al-Khatib M, Alshogran OY, Bani Amer MS. Clinical pharmacist-led medication reconciliation supplemented with medication review in admitted patients with chronic kidney disease: a cost-benefit analysis. BMJ Open 2025;15:1–9. https://doi.org/10.1136/bmjopen-2024-087232. DOI: https://doi.org/10.1136/bmjopen-2024-087232

Aronson J. Medication reconciliation. BMJ 2017;356:5336. https://doi.org/10.1136/bmj.i5336. DOI: https://doi.org/10.1136/bmj.i5336